News

Dr.Morteza Zarrabi; Managing Director of Royan Stem Cell Technology Company,  remarking to an increasing rate of samples stored with Royan Stem Cell Technology Company (more than75,000 samples  either in public or private), stated that more than 20 samples have been released by this bank so far for transplantation purposes of different malignant. He, later on, added that under the cooperation umbrella with Ministry of Health, there has been held a council of stem cells donors providing a registry of the stem cells stored  and the specification of each sample to be applied for those who seek for such a source of treatment.

Among other activities already performed, Dr.Zarrabi pointed to cell therapy center launched in pediatric center and the new collaboration made by the transplantation center in Iran, Tehran, which will lead to more samples to be released on various transplantation operations.

Also, making new research on amniotic membrane to be used as a healing way for burnt or diabetic injuries or even the chronic wounds, is under the progress and study in this center. Running a new research center on pulp stem cells is another new scientific field of activity with the approval of Company Board of Managers.

The Head of Hamedan Medicine University has also declared that this university is eager to open a scientific cooperation with Royan Research Institute and Royan Stem Cell Technology Company, since there has been a growing interest and eager among the students of this university to the achievements made or the ones under the way by Royan Research Institute and Royan Stem Cell Technology Company.

Royan Stem Cell Technology Company held its 5^th Annual Gathering, here on 20^th, Oct, 2016, in Hamedan. According to the company public Relation, the company representatives from all over the country, 27 offices nationwide, made their presence in this year gathering.

Considering the 10 years of experiences Royan Stem Cell Technology Company has achieved in collecting, sorting and storing the cord blood stem cells and its identity as the sole identity and successful enterprise providing services concerned with cord blood saving with a registry of about 65 thousands of cord blood samples in its private bank and the development an efficiency it has got through its offices, Royan Stem Cell technology Company has made great achievements in public health promotion and tackling untreatable and fatal diseases by means of applying cord blood stem cells which is among one of the key targets of the company since the beginning which was emphasized during this gathering once more.

Through this event, Mr.Ashkan Mozdgir, the head of R&D Department of Company pointed to some statistical data stating that there has been a raise of about %25 in the contracts made catching up to 7028 contracts during the first half of the year comparing with last year. Referring to this fact that there are more than 10 to 15 million cells in each Ml of blood, he also added that there has been an increase of about 155ML of samples collected in the current year compared to the previous years which will lead to an increase in cell count up to 150 to 225 million cells. Low rate of infected samples collected, taking part in number of conferences and exhibitions and holding up training courses in Royan summer school were among other activities performed by Royan Stem Cell Technology Company.

One part of this gathering went on introducing te most active centers and representatives among which the centers from Isfahan. Alborz and Khoramabad were nominated as the most active ones. Further, Ms.Saei was nominated as the best cord blood sample collector recording more than 430 samples during last year.

Based on the criteria set with the company, there have been other cord blood samples collectors from other offices and branches who were selected as the best ones as well.

Table of honors and rewards went on to the best representatives, blood collectors and other staff during this year gathering, and the view points and suggestions of the representatives and authorities were also brought up, changing their experiences to cope with probable barriers may raise in future.

A delegation from Royan Stem Cell Technology Company consisting of Dr.Zarrabi, Managing Director, Dr.Abroun, technical issues supervisor, Mr.Mozdgir, manager of R&D and Mr.Asgari, in charge of international affairs department, was dispatched to Oman on the occasion of the 6^th Oman Health Exhibition held on 20^th-22^nd, September, 2016, in Muscat. This delegation took part in this event in the form of a trading delegation formed and organized by Iran Trade Promotion Organization and could hold different B2B meetings and talks along the exhibition.

On the arrival of this trading delegation, a meeting was arranged by Iran Embassy in Oman, Muscat and Mr.Ali Bak, the Head of Iran Embassy in Musact and all the members were invited to this meeting in which some successful Iranian businessmen represented their ideas and shared their experiences with the audience. Later on, all the participants found this chance to exchange some ideas and suggestions mutually.

Through their staying, Iranian delegation seize the opportunity to visit and hold some more business talks with the authorities of the headquarters of the Public Establishment for Industrial Estates (PEIE) at the Knowledge Oasis Muscat yesterday (Tuesday) and Chamber of Commerce through which two sides shared the interests of common and tried to find some vessels of business cooperation and collaboration.

The 7^Th Mother, Baby and Child (MBC) Exhibition was held in Iran. At Tehran Permanent Fair Ground from 25^th-28^th, September, 2016. Royan Stem Cell Technology Company, same as previous years, held its booth through this event representing its services and providing information to those who sought to know more about cord blood stem cells and the expecting parents who wished to proceed with storing the cord blood samples with Royan Stem Cell Te3chnology Company.

Public awareness is one of the crucial barriers which almost all cord blood banks have been facing with all around the world and Royan Stem Cell Technology Company is striving to cope with this problem through taking advantage of various techniques, means and media.

Elham, a 12-year-old girl, could get rid of the cancer she was struggling with through her sister’s umbilical cord blood stem cells.

Elham, a 12-year-old girl from Isfahan, was diagnosed with ALL two years ago. Since then she received chemotherapy for three times as the main treatment method which turned out to be all in vain. But she was cured with her sister’s umbilical cord blood stem cells stored in Royan Stem Cell Technology Company.

” We found out about Elham’s problem two years ago.” her father states. “It coincided with when we realized that her mother is pregnant and we were expecting another baby. The physicians tried chemotherapy[y for three times which appeared with no positive results and hence they decided to apply with Bone Marrow Transplantation as the next alternative. But no sample was found among family members and relatives to match with the ones of Elham’s. When they found out that we were expecting a new baby they suggested we store the umbilical cord blood samples so that we can take advantage of the cord blood stem cells for transplantation.

He added:” Having given birth to our second baby, a girl called Fatima; we found out that her sample is a hundred percent match with the ones of Elham’s. But there still came another barrier we had to overcome and it appeared when the HLA test revealed the cell count collected from the sample is not ample considering Elham’s weight which was 60KG at the time. As the consequence, the transplantation with umbilical cord blood stem cells was rejected with the physicians’ committee for three times. But at the end, it was decided to enjoy another technique known as “Double-Cord Transplantation’ in which another sample will be added to the first one. So exploiting this technique, last autumn the transplantation was performed in Shariati hospital under the supervision of Dr.Hamidieh and the samples released for Royan Stem Cell Technology Company.

Elham’s father finds all such coincidence as a miracle because his wife had already experienced abortion for two times before Fatima, Elham’s sister, are born. All the events came into existence in an order so that they ended into a plausible scenario. We are so gratitude towards the physician team and even Royan Stem Cell Technology which provided us with such services.

Right now, Elham, in a healthy condition is following up her daily activities and school assignment to catch up with the rest of her peers. She is so surprised of this way of treatment and that her sibling could save her life. Dr.Zarrabi, Managing Director of Royan Stem Cell Technology Company, showing his happiness of the successful transplantation performed for Elham, stated that this success is achieved under the umbrella of mutual contribution of every single individual staff of Royan Stem Cell Technology Company and treatment team of hospital and praised Elham’s parents decision they have made in storing their second daughter’s umbilical cord blood wit Royan Stem Cell Technology Company.

The 17^th Royan Congress on Reproductive Medicine and the 12^th Congress on Stem Cell & Technology was held in Tehran, Iran on 31^st August and 1^st and 2^nd September, 2016. Royan Stem Cell Technology also made its active presence during this 3-day congress, enhancing public awareness in regard with umbilical cord blood collecting and storing procedures and the miraculous benefits of the stem cells driven from cord blood samples, diseases can be treated with them and the byproducts in this realm of science.

Right now, one of the main concerns cord blood banks are facing with all around the world is public awareness and correcting the misunderstanding about umbilical cord blood collection and the use of stem cells which Royan Stem Cell Technology Company is making its best to enhance people awareness and information in this regard accordingly.

Through this year congress, Dr.Morteza Zarrabi, Managing Director of Royan Stem Cell Technology Company, made a speech about the history of cord blood banks since the beginning up to now and Dr.Abroun, the Chief Technical issues Manager of Royan Stem Cell Technology Company, was awarded for an article represented by him in the congress.

Our stand, this year was a bit different with the previous ones, enjoying a business part in which our manufacturing counterparts exposed their latest medical device and instruments. 

The umbilical cord blood stem cells of Ahmad Reza’s sister stored with Royan Stem Cell Technology Company helped him get rid of the malignant he was involved with, Thalassemia.

Fatima, Ahmad Reza’s little sister, was born two years ago in Kerman and her parents decided to store her umbilical cord blood samples with Royan Stem Cell Technology Company. At that time, they had a son suffering from Thalassemia and they were busy with his treatment procedures as well.

Trying various treatment techniques, the physicians finally decided to shift their treatment approach toward applying hematopoietic stem cells. Since his sister’s umbilical cord blood sample was stored at the time of her birth, the transplantation procedures were performed in April 2016 in Shariati hospital and under the supervision of Dr.Hamidieh.

Right now and after couple of months of the transplantation made, Ahmad Reza general health condition is improving and progressing and all blood indices reveal a normal and perfect condition.

Having released from hospital, Ahmad Reza  made a visit to Royan Stem Cell Technology Company and got more oriented of the whole story happened to him.

The authorities of Royan Stem Cell Technology, hereby, express their deep gratitude towards the treatment team of Shariati hospital and wish in future more umbilical cord blood samples can be stored and more lives can be saved as the consequences.

Isabella is three-and-a-half years old, but just weeks ago, she said her brother's name for the first time. Her older brother, Matthew, 15, was diagnosed as a child with the same condition that she has: Childhood Apraxia Syndrome (CAS), which is a motor speech disorder. CAS results in problems saying sounds, syllables, and words because the brain has difficulty in planning to move the body parts that form speech, such as the lips, jaw, and tongue.

Isabella's parents, Steven and Rosa, are small business owners in Queens, New York, running a technology education business for children. Before Isabelle was born, they were considering the possibility of banking stem cells, thinking it may benefit their son. "We discovered that the amount of (cord) blood collected is often only enough for a young child," said Steven Barney.

They ultimately decided to bank Isabella's cord blood with, a private cord blood, cord tissue, and placenta tissue banking company. "We researched the cord blood transfusions being done at Duke University for Apraxia, and they had found some success. We had some initial hesitation, but you never know what the future holds." 

The Barney family traveled to Duke University where the company affiliates a laboratory, had shipped Isabella's stem cells in a cryopreservation tank. These tanks are kept at below -190 degrees Celsius, so that the cells within remain frozen during their journey from the lab to the treatment center. 

The 1^st National Festival & International Congress of Stem Cell and Regenerative Medicine was held in Tehran from 19^th-21^st of May, 2016. Considering the vast fields of activities this realm of science, Stem Cell and Regenerative Medicine, are concerned with and the wide range of diseases they have been found to cure and the growing interest and trend toward these new branches of science and technology and hence this conference has drawn the attention of lots of scientists, researchers, university students and enterprises involved or in this field of science and technology.

Royan Stem Cell Technology participated in this Festival and Congress as well holding a stand through this 3-day event and is honored to have hosted some reputable scientists in its stand such as Professor Dennis Confer from the United States and Dr.Paolo Rebulla from Italy.

Royan Stem Cell Technology is among one of nominated science-based research companies concerned with Cord Blood Banking, Stem Cell Research and HLA Banking. Referring to its active presence in this scientific and business market, so far Royan Stem Cell Technology Company has played a key role in providing and releasing samples demanded by some hospital on the purpose of transplantation and achieving fruitful results in curing patients suffering chronic diseases is cause of proud and happiness for this company.

Royan Stem Cell Technology Company invites and embraces all scientific collaborations and suggestions nationwide and worldwide and is ready to share its knowledge and experiences throughout all national and international scientific bodies.

Throughout the centuries, there have been men and women whose thoughts, actions and behaviors were considered unique and have left deep impacts on their nations and the ones following them. Among them, Imam Ali is the one who carries all positive and influencing characteristics together. The one, who showed generosity to the poor and orphans, was courage at the time of danger and expressed sympathy with the oppressed.

That is why once a year, Muslims all around the world commemorate the birthday of this great man, celebrate and hold various meetings to share their joy and happiness with the others. On the occasion of such a cheerful event, the day is called “The Father’s Day” and family members show deep respect to the grandpas and fathers through representing them some gifts and holding family reunions.

We, at Royan Stem Cell Technology, also threw a party with our colleagues and shared some time of joy and happiness with our colleagues. During the ceremony, the managing director of the company made a lecture on the topic and there was even a contest of narrating the best paragraph about “Father” and the winners received their prizes at the end of the ceremony.

Following that, a cake was shared among all staff to end the ceremony with a sweet memory, wishing each other success and happiness.

               End of the year always means lots of backlogs and you find time too cramped to handle all of them in ease. However, at times you can spot some time to share your joy with your partners and colleagues, spreading out the feelings of delight and happiness. This came into existence when the End-of-Year Ceremony was held in Royan Stem Cell Technology Company in Kowsar Gathering Hall at the site of the company.

              The ceremony was started with reading verses of Holy Koran and continued with the speech made by Dr.Zarrabi, Managing Director of the company, who expressed his great honor to the endeavor made by the all staff throughout the year.  Pointing to the achievements made during the last year and hurdles cleared on the way toward such achievements, he confessed that such a progress and development can be put into effect in the light of mere comprehensive team work and collaboration. He also remarked the targets set ahead the company for the coming year. Following his speech, he wished the best for all staff to enjoy a safe and sound year ahead.

           During this ceremony, Mr.Shirvani, an expert in theology, also was invited who represented a speech on the attitudes religions have got toward Spring and the relationship between this season and human nature. Farther, he remarked the secrets of the creation and the story falls beyond the creation of the human being and nature reviving in Spring. At the end of the ceremony, gift packages were distributed among the staff which made the happiness of the whole participants much more than before.

          Though, it was the last working day in Royan Stem Cell Technology Company, but some staff have to stay at work on different working shifts due to the nature of their position.

          Taking this opportunity, we, at Royan Stem Cell Technology Company, would hereby like to express out the best wishes for all our counterparts, clients and our compatriots all around the world.

CONGRATULATIONS THE NEW YEAR,

WISHING YOU ALL AN EVER-LASTING & NEVER-ENDING GREEN AND JOYFUL LIFE.

Top 5 Influences in the Global Cord Blood Banking Market

This post considers five of the most influential people operating within the cord blood banking marketplace. These individuals are all renowned industry experts, innovative thought leaders, and of course, highly sought after speakers, advisers, and board members. Their individual opinions on cord blood banking topics can substantially alter public perception.

As such, it is critical to be aware and educated about the role that these individuals have played – and continue to play – within the cord blood banking marketplace.

1^st Place:  Dr. Elaine Gluckman

Esteemed French doctor, Elaine Gluckman, has been performing stem cell transplantations for over 30 years. She is a founding member of the European Group of Bone Marrow Transplantation and Head of the Department of Bone Marrow Transplantation at the Hospital Saint-Louis in Paris. Dr. Elaine Gluckman performed the first successful umbilical cord transplant on a human being in 1988.

For this high achievement she has been named the “Mother of Cord Blood Transplant.” Among her many awards in the field,  she has been decorated “Legion d’honneur and the Ordre du mérité in France” and was bestowed with an honorary doctorate from the Faculty of Medicine of the University of Basel in 2005.

Currently, she is focused on researching congenital bone marrow and failure transplantation of umbilical cord blood.

2^nd Place:  Dr. Joanne Kurtzberg

Dr. Kurtzberg is best known for performing the first unrelated cord blood transplant in the world in 1993. At that time, she performed the first two successful unrelated donor cord blood transplants, one of which was used to treat a patient with acute lymphoblastic leukemia (ALL). In 1996, Dr. Joanne Kurtzberg, along with Drs. Rubinstein and Stevens, published results of unrelated cord blood transplantation from their first 25 patients in the New England Journal of Medicine.

She has built her career around developing and refining umbilical cord blood transplantation techniques. She completed her training at the New York Medical College and worked with Upstate Medical Center, Syracuse in New York and Duke University Medical Center.

As part of her current activities, Dr. Kurtzberg optimizes both clinical and laboratory-based translational research revolving around various aspects of normal and malignant hematopoiesis. Her love and passion for the field of cord blood transplant research has led her to receive the Lifetime Achievement Award from the Pediatric Blood and Marrow Transplant Consortium.

3^rd Place:  Dr. Pablo Rubinstein

Dr. Pablo Rubinstein is the co-founder and director of the National Cord Blood Program in the New York Blood Center, and his greatest achievement has been advancing knowledge and techniques within the field of cord blood banking in the U.S. and worldwide. He began his medical training in Universidad de Chile and afterwards worked both in Chile and the U.S.. To date, he has published more than two hundred research papers on the topics of immunogenetics, transplantation, cord blood banking, and similar industry topics. He is also an adjunct clinical professor at Columbia University.

Following the first sibling-donor cord blood transplant in 1988 by Dr. Elaine Gluckman (see #1), the National Institute of Health (NIH) awarded a grant to Rubinstein to develop the world’s first cord blood program at the New York Blood Center. The purpose of this public cord blood system was to create an inventory of umbilical cord blood stem cell units that could be used for medical purposes as unrelated, transplant matches.

His hard work paid off shortly thereafter, when in 1993, Dr. Joanne Kurtzberg (see #2) from Duke University successfully used cord blood stored by the New Cord Blood Center to perform a series of pioneering transplant surgeries.

4^th Place:  Dr. Hal Broxmeyer

In 1983, Dr. Hal Broxmeyer and his team were the first to suggest that umbilical cord blood could serve as an alternative source of hematopoietic stem cells for transplant, instead of bone marrow. He is the founder of CORD:USE Family Cord Blood Bank.

He was also responsible for storing the cord blood that was collected during the birth of Matthew Farrow’s sister; Matthew Farrow was a five-year old child who received the first successful cord blood transplant in the world performed by Dr. Elaine Gluckman in the St. Louis Hospital, of Paris, France. (Note: Matthew’s U.S. physician was Dr. Joanne Kurtzberg.)

In 1989, Dr. Broxmeyer published a landmark paper in the Proceedings of the National Academy of Sciences demonstrating that cord blood has similar attributes to bone marrow, including that it contains an enriched source of stem and progenitor cells. As such, he again proposed cord blood as a possible alternative to bone marrow as a source of hematopoietic stem cells for use in transplantation.

Dr. Broxmeyer has been a critical figure during the birth and gradual maturation of the cord blood banking marketplace. He has written or co-authored more than 600 papers pertaining to the science and mechanisms of cord blood stem cells. In addition, he was the 2010 President for the American Society of Hematology (ASH), which is the world’s largest professional society that addresses the causes of and remedies for blood disorders.

5^th Place:  Geoffrey Crouse

Mr. Crouse is the CEO of Cord Blood Registry (CBR), the largest cord blood bank in the United States and worldwide. CBR currently has more than a half million cord blood and cord tissue units stored in its Tucson, AZ, laboratory. Mr. Crouse was also selected as a member of the Advisory Committee for the Cord Blood Association, formed in 2014 within the United States. More recently, he was elected Vice President of this organization.

With a B.A. from Boston College and a M.B.A. and M.P.H. from the University of California at Berkeley, Mr. Crouse joined the Cord Blood Registry as its CEO in 2012. He had previously worked at other major biomedical behemoths, to include Immucor, Millipore Corporation, Roche, and more.

He is passionate about his work within the field of cord blood banking and actively promotes cord blood banking.